Balance tests while taking atogepant in adults with migraine
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests a migraine medication called atogepant (a pill) to see how it affects your sense of balance in healthy adults and in people who have migraine. It might help doctors understand if this medicine helps with the dizziness or balance problems some people with migraine have.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old.
- You either have migraine (episodic or chronic) or you are a healthy adult without migraine.
- You have no inner ear or balance problems (no vestibular disorder).
- You have not taken any migraine CGRP-blocking medicine in the last 6 months.
- You do not have severe kidney or liver disease, unstable heart disease, or a recent heart attack or stroke.
- You are not pregnant, breastfeeding, or at risk of pregnancy without effective contraception.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a daily pill called atogepant to see how it affects the brain and body in people with episodic migraine. It may help if you have 8 to 14 migraine days a month and haven't tried CGRP treatments before.
This trial studies the long-term safety (side effects over time) of atogepant tablets in children and teens with migraine. It may help families understand whether the medicine is safe for longer use in ages 6 to 17.
This trial tests an oral medication called atogepant to see if it can prevent migraines in teens aged 12–17. It aims to reduce how often migraines happen and track any side effects.
This study tests whether an oral medicine called atogepant can reduce migraine activity in children ages 6–17 and checks its side effects. It’s meant for kids with episodic migraine (not the more constant types) who may benefit from preventive treatment.
This study tests an oral medication called atogepant to prevent migraines in adults in the UK. It aims to see how well it works when prescribed by a general practitioner in primary care.
This study tests a once-daily pill, atogepant, to see if it safely prevents chronic or episodic migraines in Korean adults. It's meant for people whose doctor has already prescribed the pill for migraine prevention.
Hear when a new Migraine Disorders, Brain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.